Target-switchable nanoprobe based on BRD4 inhibition for induction and dynamic visualization of the mitochondrial

Ruijie Cao1, Yijing Dang1, Xinyue Liu1

  • 1School of Chemistry and Molecular Engineering, East China Normal University, Shanghai, 200241, China.

PubMed

Insights

Researchers developed a fluorescent probe, Cy-JQ1, to visualize mitochondrial apoptosis triggered by specific proteins. This probe enables dynamic tracking of apoptosis pathways and aids in developing targeted cancer therapies.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Molecular Medicine

Background:

  • Mitochondrial apoptosis is crucial for cancer diagnosis and treatment.
  • Visualizing protein-induced mitochondrial apoptosis in living cells remains challenging.

Purpose of the Study:

  • To design and synthesize a fluorescent probe for visualizing protein-induced mitochondrial apoptosis.
  • To develop a sensitive indicator for apoptosis dynamics.
  • To create enhanced nanoprobes for improved drug delivery and tumor targeting.

Main Methods:

  • Synthesis of the fluorescent probe Cy-JQ1 targeting bromodomain-containing protein 4 (BRD4).
  • Investigation of Cy-JQ1's effect on mitochondrial membrane potential and apoptosis signaling pathways (Bcl-2/Bax/caspase-3).
  • Development of a nanoprobe (Cy-JQ1-S-S-M) by conjugating Cy-JQ1 with PEG-disulfide bonds.

Main Results:

  • Cy-JQ1 effectively triggers apoptosis at 500 nM by impacting mitochondrial function and activating key signaling proteins.
  • The probe exhibits specific fluorescence properties, allowing visualization of its translocation from mitochondria to the endoplasmic reticulum.
  • A novel apoptosis indicator, ΔXOR, was defined based on fluorescence intensity differences.
  • The Cy-JQ1-S-S-M nanoprobe demonstrated improved pharmacokinetics and tumor accumulation.

Conclusions:

  • Cy-JQ1 provides a novel method for dynamic visualization of mitochondria-induced apoptosis pathways.
  • The developed probe and nanoprobe are valuable tools for studying apoptosis and developing targeted cancer therapies.
  • This approach facilitates the development of apoptosis-related targeted drugs.

Related Concept Videos